Cargando…

Predictors for the Recurrence of Clinically Uterine-Confined Endometrial Cancer and the Role of Cytokeratin Immunohistochemistry Stain in the Era of Sentinel Lymph Node Mapping

SIMPLE SUMMARY: Sentinel lymph node (SLN) mapping in women with endometrial cancer is gradually gaining popularity worldwide. The objectives of this retrospective study were to elucidate the predictors for cancer recurrence in the era of SLN mapping, and to compare the clinical outcomes between SLN...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ting, Wan-Hua, Hsieh, Shu-Wei, Chen, Hui-Hua, Wei, Ming-Chow, Lin, Ho-Hsiung, Hsiao, Sheng-Mou
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9031387/ https://www.ncbi.nlm.nih.gov/pubmed/35454878 http://dx.doi.org/10.3390/cancers14081973

Ejemplares similares

Comparing the efficacy of routine H&E staining and cytokeratin immunohistochemical staining in detection of micro-metastasis on serial sections of dye-mapped sentinel lymph nodes in colorectal carcinoma
por: Sanei, Mohammad Hossein, et al.
Publicado: (2016)

The uterine pathological features associated with sentinel lymph node metastasis in endometrial carcinomas
por: Kang, Yuna, et al.
Publicado: (2020)

Case report: Sentinel lymph node mapping of endometrial carcinoma occurring in uterine didelphys
por: Sassine, Dib, et al.
Publicado: (2021)

The value of immunohistochemistry in sentinel lymph node histopathology in breast cancer
por: Klevesath, M B, et al.
Publicado: (2005)

Double staining immunohistochemistry
por: Chen, Xiao, et al.
Publicado: (2010)

Immunohistochemical staining of cytokeratin 20 and cytokeratin 7 in colorectal carcinomas: Four different immunostaining profiles
por: Al-Maghrabi, Jaudah, et al.
Publicado: (2018)

BRAF immunohistochemistry predicts sentinel lymph node involvement in intermediate thickness melanomas
por: Manninen, Atte A., et al.
Publicado: (2019)

Stage II endometrial cancer requires stratification according to uterine risk factor and sentinel lymph node sampling
por: Ouh, Yung-Taek, et al.
Publicado: (2020)

Microfluidics for rapid cytokeratin immunohistochemical staining in frozen sections
por: Brajkovic, Saska, et al.
Publicado: (2017)

Identification and preservation of stained non-sentinel lymph nodes in breast cancer
por: Li, Xiaoyan, et al.
Publicado: (2020)

Sentinel Lymph Nodes in Endometrial Cancer Update 2018
por: Abdelazim, Ibrahim A., et al.
Publicado: (2019)

Status of Sentinel Lymph Node Biopsy in Endometrial Cancer
por: Taran, Florin Andrei, et al.
Publicado: (2021)

Cytokeratin Expression Pattern in Human Endometrial Carcinomas and Lymph Nodes Micrometastasis: a Mini-review
por: Vasilevska, Danuta, et al.
Publicado: (2022)

Predictors of Survival in Women with High-Risk Endometrial Cancer and Comparisons of Sandwich versus Concurrent Adjuvant Chemotherapy and Radiotherapy †
por: Chen, Hui-Hua, et al.
Publicado: (2020)

Cytokeratin 7 and 20 staining for the diagnosis of lung and colorectal adenocarcinoma
por: Kummar, S, et al.
Publicado: (2002)

Intraoperative Sentinel Lymph Node Evaluation: Implications of Cytokeratin 19 Expression for the Adoption of OSNA in Oral Squamous Cell Carcinoma
por: Shaw, Richard, et al.
Publicado: (2016)

Sentinel Lymph Node Mapping in High-Grade Endometrial Cancer
por: Salman, Lina, et al.
Publicado: (2022)

Sentinel lymph node biopsy in endometrial cancer: state of the art
por: Della Corte, Luigi, et al.
Publicado: (2020)

Applications and Safety of Sentinel Lymph Node Biopsy in Endometrial Cancer
por: Chiu, Wan Kam, et al.
Publicado: (2022)

Combined immunohistochemistry of β-catenin, cytokeratin 7, and cytokeratin 20 is useful in discriminating primary lung adenocarcinomas from metastatic colorectal cancer
por: Ikeda, Satoshi, et al.
Publicado: (2006)

A cut-off of 2150 cytokeratin 19 mRNA copy number in sentinel lymph node may be a powerful predictor of non-sentinel lymph node status in breast cancer patients
por: Terrenato, Irene, et al.
Publicado: (2017)

Technetium Tc 99m tilmanocept fails to detect sentinel lymph nodes in endometrial cancer
por: Reddy, Ravali A., et al.
Publicado: (2022)

Sentinel lymph node mapping in early stage of endometrial and cervical cancers
por: Allameh, Tajossadat, et al.
Publicado: (2015)

Laparoscopic Indocyanine Green Sentinel Lymph Node Mapping in Endometrial Cancer
por: Papadia, Andrea, et al.
Publicado: (2016)

Performance of sentinel lymph node biopsy in high-risk endometrial cancer
por: Ehrisman, Jessie, et al.
Publicado: (2016)

Update on Sentinel Lymph Node Biopsy in Surgical Staging of Endometrial Carcinoma
por: Eriksson, Ane Gerda Z, et al.
Publicado: (2021)

Sentinel Lymph Node Mapping in Endometrial Cancer: A Comprehensive Review
por: Zhai, Lirong, et al.
Publicado: (2021)

Sentinel Lymph Node Impact on the Quality of Life of Patients with Endometrial Cancer
por: García-Pineda, Virginia, et al.
Publicado: (2023)

Predictive Value of Serum Cytokeratin 19 Level for the Feasibility of Conserving Ovaries in Endometrial Cancer
por: Xu, Jie, et al.
Publicado: (2021)

Hysteroscopic endometrial biopsy with immunohistochemistry in the diagnosis of endometritis
por: Zhang, Yan, et al.
Publicado: (2021)

Injecting Patent Blue Dye V for sentinel lymph node biopsy without skin staining
por: Johnson, S, et al.
Publicado: (2012)

Significance of Matrix Metalloproteinase 9 Expression as Supporting Marker to Cytokeratin 19 mRNA in Sentinel Lymph Nodes in Breast Cancer Patients
por: Murawski, Marek, et al.
Publicado: (2016)

Cytokeratin 7-positive/cytokeratin 20-negative cecal adenocarcinoma metastatic to the uterine cervix: a case report
por: Toyoshima, Masafumi, et al.
Publicado: (2016)

Metastatic Seminoma with Positive Staining of Cytokeratin and MOC31: A Diagnostic Pitfall
por: Fan, Jiaming, et al.
Publicado: (2021)

Sentinel Lymph Node Biopsy in Uterine Cancer: Time for a Modern Approach
por: Laas, Enora, et al.
Publicado: (2023)

Role of blue dye for sentinel lymph node detection in early endometrial cancer
por: Restaino, Stefano, et al.
Publicado: (2017)

Spatially resolved proteomics identify biomarkers from endometrial sentinel lymph nodes
por: Li, Renliang, et al.
Publicado: (2021)

In-depth proteomics analysis of sentinel lymph nodes from individuals with endometrial cancer
por: Aboulouard, Soulaimane, et al.
Publicado: (2021)

Clinical factors associated with failed sentinel lymph node mapping in endometrial cancer
por: Garrett, Alison A., et al.
Publicado: (2022)

Sentinel lymph node mapping for endometrial cancer: Opportunity for medical waste reform
por: Marsh, Leah A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_04av28ik08lib3rivp9dg1l388